Sarah is the founder and CEO of Daphnia Labs, a drug discovery startup using machine learning to screen for aging-modulating drugs in vivo. Previously, she has built machine learning tools for biotech, autonomous vehicles, and cybersecurity. She received her PhD in math from Yale in 2015, focusing on manifold learning with applications to systems biology.
Related Organizations
